BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1766743)

  • 21. Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy.
    Löning L; Zimmermann M; Reiter A; Kaatsch P; Henze G; Riehm H; Schrappe M
    Blood; 2000 May; 95(9):2770-5. PubMed ID: 10779419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].
    Skoczen S; Klus K; Armata J; Kowalczyk J; Wisniewska-Slusarz H; Kolecki P; Derwich K; Matysiak M; Krauze A; Rokicka-Milewska R; Pawelec K; Boguslawska-Jaworska J; Juszczak K; Pisarek J; Sońta-Jakimczyk D; Tomaszewska R; Łuszczynska A; Wysocki M; Styczyński J
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):23-32. PubMed ID: 12021459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk classification at the time of diagnosis differentially affects the level of residual disease in children with B-precursor acute lymphoblastic leukemia after completion of therapy.
    Okcu MF; Roberts WM; Johnston DA; Ouspenskaia MV; Papusha VZ; Brandt MA; Zipf TF
    Leuk Res; 2003 Aug; 27(8):743-50. PubMed ID: 12801533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.
    Paganin M; Zecca M; Fabbri G; Polato K; Biondi A; Rizzari C; Locatelli F; Basso G
    Leukemia; 2008 Dec; 22(12):2193-200. PubMed ID: 18754029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is high dose methotrexate without irradiation of the brain sufficiently effective in prevention of CNS disease in children with acute lymphoblastic leukemia?
    Cáp J; Foltinová A; Kaiserová E; Mojzesová A; Sejnová D; Jamárik M
    Neoplasma; 1998; 45(3):176-9. PubMed ID: 9717531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of childhood acute leukemia: a long-term follow-up study of CCLSG-high risk ALL 811 (phase III study). Children's Cancer & Leukemia Study Group].
    Mimaya J; Fujimoto T; Takeda T; Yanai M; Yatabe M; Utumi J; Hiyosi Y; Koizumi S; Tanaka K; Yaoi K
    Rinsho Ketsueki; 1988 Sep; 29(9):1357-64. PubMed ID: 3063852
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lineage switch - conversion of acute lymphoblastic leukaemia to acute myeloid leukaemia in 4 years old girl].
    Szpecht D; Derwich K; Wachowiak J; Konatkowska B; Dworacki G
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1041-4. PubMed ID: 19531823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.
    Eckert C; Henze G; Seeger K; Hagedorn N; Mann G; Panzer-Grümayer R; Peters C; Klingebiel T; Borkhardt A; Schrappe M; Schrauder A; Escherich G; Sramkova L; Niggli F; Hitzler J; von Stackelberg A
    J Clin Oncol; 2013 Jul; 31(21):2736-42. PubMed ID: 23775972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High methotrexate doses in the treatment program for acute lymphoblastic leukemia and lymphosarcoma in children].
    Makhonova LA; Maiakova SA; Kiselev AV; Gordina GA; Balakirev SA; Gavrilova IE; Moiseenko EI; Morozova OV
    Vopr Onkol; 1990; 36(10):1196-200. PubMed ID: 2251813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALL-BFM 95 treatment in Turkish children with acute lymphoblastic leukemia--experience of a single center.
    Kocak U; Gursel T; Kaya Z; Aral YZ; Albayrak M; Keskin EY; Belen B; Isık M; Oner N
    Pediatr Hematol Oncol; 2012 Mar; 29(2):130-40. PubMed ID: 22376016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of acute lymphoblastic leukemia in children according to the ALL-BFM-90m protocol in the Russian Federation and the Republic of Belarus].
    Miakova NV; Aleĭnikova OV; Hartmann R; Rudneva AE; Trubina NM; Fechina LG; Timakov AM; Shamardina AV; Lebedev VV; Varfolomeeva SIu; Dudkin SD; Dyshlevaia ZM; Timofeeva VN; Rumiantsev AG; Henze H; Karachunskiĭ AI
    Vopr Onkol; 2002; 48(3):347-51. PubMed ID: 12455360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial.
    Conter V; Valsecchi MG; Silvestri D; Campbell M; Dibar E; Magyarosy E; Gadner H; Stary J; Benoit Y; Zimmermann M; Reiter A; Riehm H; Masera G; Schrappe M
    Lancet; 2007 Jan; 369(9556):123-31. PubMed ID: 17223475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].
    Badowska W
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1001-7. PubMed ID: 19531816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood leukemia: cooperative Berlin-Frankfurt-Münster trials in the Federal Republic of Germany.
    Ritter J; Creutzig U; Reiter A; Riehm H; Schellong G
    J Cancer Res Clin Oncol; 1990; 116(1):100-3. PubMed ID: 2179227
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term follow up of therapy-conditioned cerebral changes in acute lymphatic leukemia].
    Jung G; Lanfermann H; Benz-Bohm G; Berthold F
    Rofo; 1995 May; 162(5):450-2. PubMed ID: 7772770
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of childhood acute leukemias: present concepts.
    Advani SH; Nair R
    Indian Pediatr; 1993 May; 30(5):589-91. PubMed ID: 8282385
    [No Abstract]   [Full Text] [Related]  

  • 38. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.
    Nachman JB; Sather HN; Sensel MG; Trigg ME; Cherlow JM; Lukens JN; Wolff L; Uckun FM; Gaynon PS
    N Engl J Med; 1998 Jun; 338(23):1663-71. PubMed ID: 9614257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
    Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapy of acute lymphoblastic leukemia in adults.
    Hoelzer D
    Leukemia; 1992; 6 Suppl 2():132-5. PubMed ID: 1578915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.